Kepos Capital’s iSpecimen ISPC Stock Holding History

Kepos Capital’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-238	Closed	-$1.48M	–	629
2021 Q4	$1.48M	Sell	238 -43	-15%	-$309K	0.12%	183
2021 Q3	$1.31M	Hold	281	–	–	0.09%	276
2021 Q2	$1.63M	Buy	+281	New	+$1.62M	0.12%	238

Other funds holding ISPC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Kepos Capital's ISPC Position: Q1 2022 in Review

Kepos Capital sold out of iSpecimen (ISPC) in Q1 2022, closing a stake of 238 shares — an estimated $1.48M sold.

Kepos Capital first reported a position in ISPC in Q2 2021 and held it in 3 quarters. The position peaked at $1.63M in Q2 2021. 12 funds tracked by Wall St. Rank hold ISPC as of Q1 2022.

Kepos Capital reported no remaining iSpecimen position as of Q1 2022 after selling out during the quarter.
Kepos Capital sold 238 iSpecimen shares in Q1 2022, an estimated $1.48M.
Kepos Capital first reported a position in iSpecimen in Q2 2021 and held it in 3 quarters.
Kepos Capital's iSpecimen position peaked at $1.63M in Q2 2021.
12 funds tracked by Wall St. Rank held iSpecimen as of Q1 2022.

Based on Kepos Capital's 13F filing for Q1 2022, filed 13 May 2022.